Given that high KLF4 expression associates with a more epithelial phenotype, these results, when extrapolated to indicate the extent of EMT/MET, suggest that EMT associates with a worse survival in breast cancer but not necessarily in ovarian cancer and lung cancer, as far as these limited datasets being analyzed are concerned. The gene discussed is KLF4; the disease is lung cancer.